Coronary interventions
How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials May 20, 2019 | 10.4244/EIJ-D-18-00607
Showing 1-8 of 8 articles
Coronary interventions
Serial comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polymer coated everolimus-eluting Xience stent: 6- and 24-month results of DESSOLVE III OCT sub-study May 7, 2019 | 10.4244/EIJ-D-18-01201
Coronary interventions
Interventional cardiology 2018: the year in review April 5, 2019 | 10.4244/EIJ-D-19-00040
Coronary interventions
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial March 17, 2019 | 10.4244/EIJ-D-19-00202
Coronary interventions
Two-year follow-up of the DESSOLVE III trial: bioabsorbable polymer sirolimus-eluting stent vs. durable polymer everolimus-eluting stent. February 5, 2019 | 10.4244/EIJ-D-18-00944
Coronary interventions
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial December 20, 2018 | 10.4244/EIJ-D-18-00461
Coronary interventions
How does the failure of Absorb apply to the other bioresorbable scaffolds?: Expert review of first-in-man and pivotal trials. November 6, 2018 | 10.4244/EIJ-D-18-00607
Coronary interventions
A prospective multicenter randomized all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the TALENT trial July 31, 2018 | 10.4244/EIJ-D-18-00499
